NPPA issued a notification regarding the fixation of the retail price of Paracetamol IP 500 mg Oral Suspension for M/s Naxpar Pharma Pvt. Ltd. (Manufacturer) & M/s Glaxosmithkline Pharmaceuticals Ltd. (Marketer)

Jun 25, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on June 08, 2026, issued a notification regarding the fixation of the retail price of Paracetamol IP 500 mg Oral Suspension for M/s Naxpar Pharma Pvt. Ltd. (Manufacturer) & M/s Glaxosmithkline Pharmaceuticals Ltd. (Marketer).

It states that the price for each 5 ml containing Paracetamol IP 500 mg Oral Suspension has been fixed at Rs. 0.66/- excluding GST.

[Notification no. - 19(5204)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT